fingolimod hydrochloride has been researched along with Sjogren's Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, PL; McCulloch, A | 1 |
| Fratta, M; Lus, G; Sagliocchi, A; Signoriello, E | 1 |
| Cocco, G | 1 |
3 other study(ies) available for fingolimod hydrochloride and Sjogren's Syndrome
| Article | Year |
|---|---|
Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model.
Topics: Administration, Oral; Animals; Disease Models, Animal; Female; Fingolimod Hydrochloride; Humans; Male; Mice; Mice, Transgenic; Saliva; Salivary Glands; Sjogren's Syndrome | 2020 |
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Sjogren's Syndrome; Sphingosine | 2015 |
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?
Topics: Arthritis, Psoriatic; Atrial Fibrillation; Autoimmune Diseases; Celecoxib; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Factor V; Fingolimod Hydrochloride; Heart; Heart Diseases; Heart Failure; Humans; Hypertension; Immunosuppressive Agents; Male; Middle Aged; Mitral Valve Insufficiency; Multiple Sclerosis; Mutation; Myocardium; Propylene Glycols; Pyrazoles; Sjogren's Syndrome; Sphingosine; Sulfonamides | 2012 |